99 related articles for article (PubMed ID: 3994400)
1. [Effect of KW-2083 in Stage D adenocarcinoma of the prostate].
Yoshimoto J; Ochi J; Nasu Y; Obama T; Tsushima T; Matsumura Y; Ohmori H
Gan To Kagaku Ryoho; 1985 May; 12(5):1156-7. PubMed ID: 3994400
[No Abstract] [Full Text] [Related]
2. [Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
Nishiyama M; Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3133-7. PubMed ID: 3142368
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
[TBL] [Abstract][Full Text] [Related]
4. [Effect of 7-N-(P-hydroxyphenyl)-mitomycin C (KW-2083) against pleuritis carcinomatosa].
Shimizu E; Saijo N; Shinkai T; Eguchi K; Tominaga K; Nomori H; Sasaki Y; Garcia-Herreros P; Hoshi A
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1290-5. PubMed ID: 6732255
[TBL] [Abstract][Full Text] [Related]
5. Third-line chemotherapy with mitomycin, vinblastine, and carmustine (BCNU) in refractory breast carcinoma: a pilot study.
Veronesi A; Tirelli U; Galligioni E; Trovò MG; Crivellari D; Donatella Magri M; Roncadin M; Tumolo S; Grigoletto E
Cancer Treat Rep; 1982 Mar; 66(3):559-61. PubMed ID: 7060044
[No Abstract] [Full Text] [Related]
6. Intravesical chemotherapy--frequency of instillation.
Smith PH
Prog Clin Biol Res; 1985; 185B():57-68. PubMed ID: 3929271
[No Abstract] [Full Text] [Related]
7. Chemotherapy of hormone refractory prostatic cancer.
Stoter G; Jones WG
Prog Clin Biol Res; 1988; 260():123-5. PubMed ID: 3129730
[No Abstract] [Full Text] [Related]
8. [Treatment of metastasizing prostatic carcinoma with DMF. Presentation of a prospective study].
Burk K; Gropp C; Rodeck G
Urologe A; 1983 Sep; 22 Suppl():347-9. PubMed ID: 6415885
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases in hormone refractory prostate cancer: a changing natural history?
Roberts-Thomson R; Rosenthal MA; Gonzales M; Drummond K
Intern Med J; 2009 Mar; 39(3):205-6. PubMed ID: 19383072
[No Abstract] [Full Text] [Related]
10. [A case of prostate cancer treated with combined androgen-blockade].
Kurita M; Kato Y; Tamura Y; Suzuki K; Yamanaka H
Gan To Kagaku Ryoho; 2000 Feb; 27(2):307-10. PubMed ID: 10700907
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.
Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL
Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755
[TBL] [Abstract][Full Text] [Related]
12. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
Wakisaka M; Takagishi H
Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
[TBL] [Abstract][Full Text] [Related]
13. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
Pollack A; Horwitz EM
Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
[No Abstract] [Full Text] [Related]
14. Chemotherapy of hormone-resistant carcinoma of the prostate: 4-epi-rubicin weekly v.s. DMF monthly.
Burk K; Sropp C; Schultze-Seemann W; de Riese W
Prog Clin Biol Res; 1987; 243B():243-6. PubMed ID: 3116556
[No Abstract] [Full Text] [Related]
15. [Changes in cancer associated cellular proteins after administration of antitumor agent using 2-dimensional PAGE--index of efficacy of antitumor agents].
Takahashi T; Takami H; Sadahiro S; Okuda K; Yamataka K; Kodaira S; Abe O; Ishimura Y
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):19-27. PubMed ID: 3084687
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of stomach cancer].
Gropp C; Havemann K
Z Gastroenterol; 1982 Dec; 20(12):703-9. PubMed ID: 6819730
[TBL] [Abstract][Full Text] [Related]
17. [Antiblastic chemotherapy in esophageal cancer].
Cartei G
Radiol Med; 1983; 69(7-8):597-600. PubMed ID: 6322245
[No Abstract] [Full Text] [Related]
18. [Evaluation of the effectiveness of cisplatin in the treatment of disseminated cancer of the prostate].
Nogueira March JL; Ojea A; Jamardo D; Díez E; Figueiredo L
Arch Esp Urol; 1985; 38(1):28-34. PubMed ID: 4039554
[No Abstract] [Full Text] [Related]
19. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
[TBL] [Abstract][Full Text] [Related]
20. [A pilot study of low dose etoposide therapy for recurrenced prostate cancer in complicated over 75 years old stage D2 cases].
Wada T; Onodera S; Tashiro K; Iizuka N; Asano K; Yanada S; Takeuchi H; Ohishi Y
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1851-4. PubMed ID: 8937498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
